Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Consumers Want More Info from Drug Makers: JPMA Survey
November 18, 2002
- GSK Reports Results of Major Survey on COPD
November 18, 2002
- MPC: Merger Synergism Boosts Sales, Profits
November 18, 2002
- DIAGNOSTIC NEWS IN BRIEF
November 18, 2002
- Arrow Japan to Diversify Business from Critical Care Products
November 18, 2002
- Ajinomoto Takes Over Shimizu Pharm
November 11, 2002
- JPA to Conduct Studies on Medical Benefits of Bungyo
November 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 11, 2002
- Tanabe Shifts to Independent Global Marketing
November 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 11, 2002
- Korosho to Standardize Definition, Duties of SMOs
November 11, 2002
- PI Forum Member Companies Maintain Interest in Drug Business
November 11, 2002
- TV Programs Should Be More Careful in Handling Healthcare Issues: Yamanouchi, Pfizer Seminar
November 11, 2002
- Roche Diagnostics: Accu-chek Compact Blood Glucose Meter
November 11, 2002
- FPMAJ Compiles Measures to Prevent Medical Accidents
November 11, 2002
- Life Science Summit Calls For Promotion of World's Leading R&D
November 11, 2002
- WORLD NEW IN BRIEF
November 11, 2002
- WEBSITE NEWS
November 11, 2002
- Researcher-led Clinical Trials on Anticancer Agents by NPO Introduced
November 11, 2002
- BUSINESS NEWS IN BRIEF
November 11, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…